ACTU
Actuate Therapeutics, Inc.Company with tickers: ACTU
CIK
1652935
CUSIP
005083100
Shares Outstanding
23,925,852
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $5,705,956 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $2,565,244 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-5,705,956 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-5,625,749 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.24 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.24 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |